Wenxuan Zhang

Dr. Wenxuan Zhang

orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
HGHui-Hui Guo
Hui-Hui Guo
CFChen-Lin Feng
Chen-Lin Feng
WZWenxuan Zhang
Wenxuan Zhang
ZLZhi-Gang Luo
Zhi-Gang Luo
HZHong-Juan Zhang
Hong-Juan Zhang
JJJian-dong Jiang
Jian-dong Jiang
Cardiovascular and metabolic disease (CMD) remains a main cause of premature death worldwide. Berberine (BBR), a lipid-lowering botanic compound with diversified potency against metabolic disorders, is a promising candidate for ameliorating CMD. The liver is the target of BBR so that liver-site accumulation could be important for fulfilling its therapeutic effect. In this study a rational designed micelle (CTA-Mic) consisting of α-tocopheryl hydrophobic core and on-site detachable polyethylene glycol-thiol shell is developed for effective liver deposition of BBR. The bio-distribution analysis proves that the accumulation of BBR in liver is increased by 248.8% assisted by micelles. Up-regulation of a range of energy-related genes is detectable in the HepG2 cells and in vivo. In the high fat diet-fed mice, BBR-CTA-Mic intervention remarkably improves metabolic profiles and reduces the formation of aortic arch plaque. Our results provide proof-of-concept for a liver-targeting strategy to ameliorate CMD using natural medicines facilitated by Nano-technology.

8 June 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
ZCZhuo Cheng
Zhuo Cheng
BHBei-Bei He
Bei-Bei He
KLKangfan Lei
Kangfan Lei
YGYing Gao
Ying Gao
YSYuqi Shi
Yuqi Shi
YLYongxin Li
Yongxin Li
Antimicrobial resistance remains a significant global threat, driving up mortality rates worldwide. Ribosomally synthesized and post-translationally modified peptides have emerged as a promising source of novel peptide antibiotics due to their diverse chemical structures. Here, we report the discovery of new aminovinyl-(methyl)cysteine (Avi(Me)Cys)-containing peptide antibiotics through a synergistic approach combining biosynthetic rule-based omics mining and heterologous expression. We first bioinformatically identify 1172 RiPP biosynthetic gene clusters (BGCs) responsible for Avi(Me)Cys-containing peptides formation from a vast pool of over 50,000 bacterial genomes. Subsequently, we successfully establish the connection between three identified BGCs and the biosynthesis of five peptide antibiotics via biosynthetic rule-guided metabolic analysis. Notably, we discover a class V lanthipeptide, massatide A, which displays excellent activity against gram-positive pathogens, including drug-resistant clinical isolates like linezolid-resistantS. aureusand methicillin-resistantS. aureus, with a minimum inhibitory concentration of 0.25 μg/mL. The remarkable performance of massatide A in an animal infection model, coupled with a relatively low risk of resistance and favorable safety profile, positions it as a promising candidate for antibiotic development. Our study highlights the potential of Avi(Me)Cys-containing peptides in expanding the arsenal of antibiotics against multi-drug-resistant bacteria, offering promising drug leads in the ongoing battle against infectious diseases.

1 October 2017 in Biomaterials
Verified
Journal Article
Closed access
LWLu-Lu Wang
Lu-Lu Wang
CFChen-Lin Feng
Chen-Lin Feng
WZWen-Sheng Zheng
Wen-Sheng Zheng
SHShuai Huang
Shuai Huang
WZWenxuan Zhang
Wenxuan Zhang
JJJian-dong Jiang
Jian-dong Jiang

1 April 2017 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
BLBo Li
Bo Li
JWJun Wu
Jun Wu
WZWenxuan Zhang
Wenxuan Zhang
ZLZhongwen Li
Zhongwen Li
GCGang Chen
Gang Chen
SWSong Wu
Song Wu

20 November 2023 in Chemical Engineering Journal
Verified
Journal Article
Open access
GCGuiyuan Cai
Guiyuan Cai
Yu TianYu Tian
Yu Tian
LLLipin Li
Lipin Li
WZWenxuan Zhang
Wenxuan Zhang
RHRui Huang
Rui Huang
Yifeng ZhangYifeng Zhang
Yifeng Zhang

22 April 2016 in RSC Advances
Verified
Journal Article
Closed access
PDF file
WZWenxuan Zhang
Wenxuan Zhang
JWJun Wu
Jun Wu
BLBo Li
Bo Li
JXJie Xia
Jie Xia
HWHongna Wu
Hongna Wu
SWSong Wu
Song Wu
20-epi-Salinomycin and six 20-O-acylated analogs were synthesized and tested for their antiproliferative activity. Both the C1-protecting group of the salinomycin and the acidity of the substituted benzoic acid are crucial to the Mitsunobu conversion. 20-epi-Salinomycin showed similar antiproliferative activity as salinomycin, but its 20-O-acylated analogs were 2–10 times more potent. In addition, the 20-epi-20-O-acylated salinomycin derivative 9d and 9e had better selectivities than salinomycin between cancer and neuron cell lines. The spatial configuration of the C20-hydroxyl group has little influence on the activities, but the acyl groups cause an obvious difference by producing possible effects on the stability and permeability of the salinomycin–alkali metal ions complexes.